Proposed bill targets prostate cancer misdiagnoses January 02, 2018By Bob GattyLegislation that advocates believe would significantly reduce prostate cancer misdiagnoses is making its way through Congress and has the support of major urologic organizations and prostate cancer interest groups.
In this issue
Combined imaging technique feasible in POP repair January 03, 2018By Andrew BowserReconstruction of anterior compartment defects using magnetic resonance-visible vaginal mesh implants in combination with post-surgical three-dimensional imaging is feasible and yields reproducible results, researchers report.
Genetic testing for prostate Ca: What the experts sayA recently published statement provides an evidence-based, consensus-driven framework on the role of genetic testing for determining prostate cancer risk, screening, and management.
Liquid biopsy tests for prostate Ca show low congruence January 05, 2018By Andrew BowserThe findings “[raise] the specter that patients could potentially receive different treatments depending on the cell-free DNA platform,” authors of a recent research letter write.
Medical field no stranger to sexual harassmentIn 2017, a flood of accusations against high-profile men in positions of power in Hollywood, the U.S. government, and the national media have focused the nation’s attention on sexual harassment and its consequences. The medical workplace is not immune from harassment, and the national conversation presents an opportunity for health care businesses to review their risk, policies, and prevention strategies. How to form a student loan repayment strategyForming a student loan repayment strategy is not a one-size-fits-all process. What works well for a friend or colleague may not be an effective strategy for you.
The switch to OTC: Are urologic drugs next?Switching a medication from prescription to over-the-counter status comes with challenges and risks, and is not always successful. In this interview, Roger Dmochowski, MD, discusses the pros and cons of OTC medications and explains the hurdles facing potential OTC products for urologic conditions. Tax law may threaten Medicare, provider pay January 12, 2018By Ally Lopshire"Perhaps the biggest Medicare reform concern for urologists is the potential for provider reimbursements cuts, a threat that has continued to loom over the health care community for some time," writes the AACU's Ally Lopshire. How important is urology/gynecology collaboration? January 12, 2018By Karen Nash"It’s absolutely important. Because we have so much overlap in our patient population, our patients are best served by us working together," says one urologist.
5 years and 50 blogs later: Big lessons from the real world January 12, 2018By Henry Rosevear MDUrologist Henry Rosevear, MD, reflects on the three lessons he's learned in 5 years of practicing urology. How to manage your reputation, recruit patients online January 17, 2018By Jamin Brahmbhatt MDIn today’s digital world, having an active professional presence online has become a must. Is favorable-risk GG2 prostate Ca suitable for active surveillance? January 18, 2018By Badar M. Mian MD"The management of prostate cancer always requires caution to safeguard against avoidable risks from both the treatment and the monitoring protocol," writes Badar M. Mian, MD. Low-oxalate diet more beneficial than supplementA preliminary analysis of data from a randomized controlled trial supports the efficacy of a low-oxalate diet for reducing urinary oxalate excretion in patients with idiopathic hyperoxaluria, but shows little or no benefit for daily dietary supplementation with vitamin B6 25 mg/magnesium 400 mg or a diet-supplement combination.
How to code for robotic cystolithotomy, diverticulectomy"When submitting an unlisted code for a procedure, you of course need to submit your documentation and we recommend a cover letter or explanation of the service including a comparative value or charge based on a similar code," write Ray Painter, MD, and Mark Painter. Ureteroscopy stone-free rates ‘disappointingly low’A study analyzing stone-free rates after ureteroscopy suggests that urologists might consider applying refined patient selection criteria in order to achieve better outcomes. Role of blue light cystoscopy to detect bladder cancer"Numerous clinical studies have exhibited significantly improved tumor detection rates with BLC," write Zachary L. Smith, MD, and Norm D. Smith, MD. CT texture analysis may aid risk stratification of renal masses January 29, 2018By Randy DotingaA recent study suggests experimental "texture analysis" of renal masses via computed tomography scan holds promise as a technique to allow more effective risk stratification.
BLC scores well against WLC in recurrent bladder tumors January 29, 2018By Randy DotingaFluorescent blue light cystoscopy improves 3-year recurrence-free survival rates in patients with recurrent bladder tumors compared to white light cystoscopy, and researchers believe its use should be expanded.
Progress on penile transplant moves forward January 01, 2018By Randy Dotinga"[Penile transplantation] is a real advance for patients who have a penile deficiency or penile loss," says Arthur L. Burnett, II, MD, MBA. Penile transplant guidelines missing in action January 01, 2018By Randy DotingaThere are no national or international guidelines regarding penile transplants, raising a question without a concrete answer: What are the rules and the limits? What new technology will you adopt in 2018? February 01, 2018By Karen Nash“My practice has seen a tremendous increase in patients’ awareness of HIFU as a treatment option," says one urologist. Uro Pipeline: FDA accepts priority review application for RCC treatment
February 07, 2018Agents for bladder cancer, prostate cancer, and stress urinary incontinence are also included in this round-up of pipeline developments.
New Products: BPH surgical robot granted FDA de novo request
February 07, 2018Other products highlighted in this round-up include a plate for studying infections caused by the long-term use of catheters and a new indication for sunitinib malate (SUTENT).
Unplanned encounters common after ureteroscopyFindings of a retrospective study confirm that unplanned encounters are common after ureteroscopy. Quality of stone care: We can do betterA recent study "revealed that inadequate pain control, presence of a ureteral stent, and a first-time stone treatment were the most common reasons for unplanned utilization of health care services [following ureteroscopy]," writes Brian R. Matlaga, MD, MPH. URS techniques: When to choose dusting vs. basketing February 01, 2018By Stephen Y. Nakada MDWhen treating kidney stones, debate continues over the use of dusting versus basketing. In this interview, Olivier Traxer, MD, describes both methods, lists his preferred laser settings, and explains why he changed the way he uses ureteral access sheaths.